Cargando…

Carbapenem Resistant Pseudomonas aeruginosa Infections in Elderly Patients: Antimicrobial Resistance Profiles, Risk Factors and Impact on Clinical Outcomes

OBJECTIVE: The prevalence and clinical impact on mortality of carbapenem-resistant Pseudomonas aeruginosa (CRPA) infection are unclear in elderly patients. Here, we aimed to clarify the prevalence, the clinical manifestations, antimicrobial resistance, risk factors and outcomes of elderly inpatients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Jie, Zou, Chengyun, Tao, Jianmin, Wei, Tian, Yan, Li, Zhang, Yufei, Wang, Haiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064054/ https://www.ncbi.nlm.nih.gov/pubmed/35517901 http://dx.doi.org/10.2147/IDR.S358778

Ejemplares similares

Resistance of Animal Strains of Pseudomonas aeruginosa to Carbapenems
por: Haenni, Marisa, et al.
Publicado: (2017)

Carbapenem-resistant Pseudomonas aeruginosa and carbapenem use in Japan: an ecological study
por: Terahara, Fumitaka, et al.
Publicado: (2019)

Ceftolozane/Tazobactam Resistance and Mechanisms in Carbapenem-Nonsusceptible Pseudomonas aeruginosa
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)

Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study
por: Vivo, Amanda, et al.
Publicado: (2022)

Risk Factors and Outcomes of Patients with Carbapenem-Resistant Pseudomonas aeruginosa Bloodstream Infection
por: Wei, Xianzhen, et al.
Publicado: (2023)

Screening of Antimicrobial Resistance Genes and Epidemiological Features in Hospital and Community-Associated Carbapenem-Resistant Pseudomonas aeruginosa Infections
por: Çopur Çiçek, Ayşegül, et al.
Publicado: (2021)

Carbapenem Susceptibility and Multidrug-Resistance in Pseudomonas aeruginosa Isolates in Egypt
por: Hashem, Hany, et al.
Publicado: (2016)

Spread of Carbapenem Resistance by Transposition and Conjugation Among Pseudomonas aeruginosa
por: van der Zee, Anneke, et al.
Publicado: (2018)

Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa
por: Gill, Christian M, et al.
Publicado: (2022)

Correlation Between Virulence Genotype and Fluoroquinolone Resistance in Carbapenem-Resistant Pseudomonas aeruginosa
por: Cho, Hye Hyun, et al.
Publicado: (2014)

Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption
por: Ribeiro, Ághata Cardoso da Silva, et al.
Publicado: (2019)

Detection of Metallo-Beta Lactamases Among Carbapenem-Resistant Pseudomonas aeruginosa
por: Farajzadeh Sheikh, Ahmad, et al.
Publicado: (2014)

Carbapenem-resistant Pseudomonas aeruginosa: association with virulence genes and biofilm formation
por: Rossi Gonçalves, Iara, et al.
Publicado: (2016)

Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa, Zhejiang Province, China
por: Hu, Yan-Yan, et al.
Publicado: (2019)

Challenges of Carbapenem-resistant Pseudomonas aeruginosa in Infection Control and Antibiotic Management
por: Kim, Young Jin, et al.
Publicado: (2024)

Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
por: Li, Shuang, et al.
Publicado: (2018)

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2018)

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2017)

Characterization of Pseudomonas aeruginosa with discrepant carbapenem susceptibility profile
por: Pragasam, Agila K., et al.
Publicado: (2016)

Characterization of antimicrobial resistance mechanisms in carbapenem-resistant Pseudomonas aeruginosa carrying IMP variants recovered from a Mexican Hospital
por: López-García, Alma, et al.
Publicado: (2018)

Risk factors and outcome associated with coinfection with carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumanii: a descriptive analysis
por: Sophonsri, Anthony, et al.
Publicado: (2023)

Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis
por: Liu, Qianqian, et al.
Publicado: (2015)

Special Issue: “Antimicrobial Resistance in Pseudomonas aeruginosa”
por: Hernando-Amado, Sara, et al.
Publicado: (2023)

Novel Insight of Transcription Factor PtrA on Pathogenicity and Carbapenems Resistance in Pseudomonas aeruginosa
por: Zhang, Ying, et al.
Publicado: (2022)

588. Ceftolozane/Tazobactam Susceptibility of Carbapenem-Resistant Pseudomonas aeruginosa and Carbapenem-Resistant Enterobacterales Isolates in a Tertiary Hospital in Korea
por: Kim, Kye-Hyung, et al.
Publicado: (2023)

Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015
por: Walters, Maroya Spalding, et al.
Publicado: (2019)

Mechanisms for Rapid Evolution of Carbapenem Resistance in a Clinical Isolate of Pseudomonas aeruginosa
por: Xu, Congjuan, et al.
Publicado: (2020)

Carbapenem-resistant Pseudomonas Aeruginosa Originating from Farm Animals and People in Egypt
por: Elshafiee, Esraa A., et al.
Publicado: (2019)

85. The Impact of Carbapenem-Sparing Interventions on the Evolution of Resistance in Pseudomonas aeruginosa in the USA
por: Townsend, Jeffrey, et al.
Publicado: (2020)

Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa
por: Hu, Yanyan, et al.
Publicado: (2021)

Association between Consumption of Fluoroquinolones and Carbapenems and Their Resistance Rates in Pseudomonas aeruginosa in Argentina
por: Boni, Silvia, et al.
Publicado: (2022)

Anti-bacterial mechanism of baicalin-tobramycin combination on carbapenem-resistant Pseudomonas aeruginosa
por: Jin, Li-Min, et al.
Publicado: (2023)

Investigating the Antagonistic Effect of Indigenous Probiotics on Carbapenem-Resistant Pseudomonas aeruginosa Strains
por: Ghiaei, Azita, et al.
Publicado: (2023)

Evolving landscape of carbapenem-resistant Pseudomonas aeruginosa at a single centre in the USA
por: Sakurai, Aki, et al.
Publicado: (2023)

Combination of AS101 and Mefloquine Inhibits Carbapenem-Resistant Pseudomonas aeruginosa in vitro and in vivo
por: Li, Rongrong, et al.
Publicado: (2023)

P1527: ASSESSMENT OF RISK FACTORS AND ANTIMICROBIAL THERAPY FOR CARBAPENEM-RESISTANT PSEUDOMONAS AERUGINOSA BLOODSTREAM INFECTIONS IN HEMATOLOGICAL PATIENTS
por: Chen, Zhangjie, et al.
Publicado: (2023)

1219. Unfavorable Clinical Outcomes with Polymyxins Compared to Ceftolozane/Tazobactam for the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa
por: Howard-Anderson, Jessica, et al.
Publicado: (2021)

High Expression of Metallo-β-Lactamase Contributed to the Resistance to Carbapenem in Clinical Isolates of Pseudomonas aeruginosa from Baotou, China
por: Xu, Yanfeng, et al.
Publicado: (2020)

Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance
por: Rizek, Camila, et al.
Publicado: (2014)

Carbapenem Resistance Determinants Acquired through Novel Chromosomal Integrations in Extensively Drug-Resistant Pseudomonas aeruginosa
por: Janice, Jessin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_911unva7ufirsgvlvpd5stgs1u